Researchers may have discovered a better way to distinguish acute leukaemia patients who require aggressive treatment to prevent recurrence from those who need only standard therapy for cure. The ...
... both leukaemia and solid tumours, there exists among the multitude of warrior cancer cells a small ... either cancer initiating cells (CICs) or leukaemia initiating cells (LICs), these stealth populations ...
Stem cell researchers at UCLA have identified a type of leukaemia stem cell and uncovered the molecular and genetic mechanisms that cause a normal blood stem cells to become cancerous...
... different types of a particularly aggressive group of blood cancers known as mixed lineage leukaemias (MLL) and how the disease might be treated, according to a study in the 9 June issue of Cancer ...
... led by cancer researchers at Ohio State University shows that a mutation present in some cases of acute leukaemia makes the disease more susceptible to high doses of a particular anticancer drug...
... that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukaemia (CML). The model takes into account the natural anti-leukaemia response in patients that are treated ...
... , a tumour-inhibiting novel protein discovered by Temple University researchers, may also have a role as a new therapeutic application in treating leukaemia, according to a study by the researchers...
... in Germany have discovered that methadone, an agent used to break addiction to opioid drugs, has surprising killing power against leukaemia cells, including treatment resistant forms of the cancer...
... , a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the ...
... School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukaemia. Their discovery hinges on a novel 'double agent' role for a molecular signal that regulates cell ...
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukaemias in hours instead of weeks, according to a study by researchers at the Stanford University School of ...
A recently identified cancer-causing protein makes the anti-leukaemia drug imatinib, less effective. By blocking the protein, an international team of researchers was able to slow the spread of ...
Each year, some 29,000 adults and 2,000 children are diagnosed with leukaemia, a form of cancer that is caused by the abnormal production of white blood cells in the bone marrow. Current treatments ...
... the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukaemia...
... discovered what could be a novel drug target for an often difficult-to-treat form of leukaemia. The investigators have identified a unique 'signature' or pattern of a specific family of enzymes in ...
